Actionable news
All posts from Actionable news
Actionable news in RPTP: Raptor Pharmaceutical Corp.,

Raptor Pharma's RP103 fails to beat placebo in pediatric NASH study; shares slump 15% premarket

Raptor Pharmaceuticals (NASDAQ:RPTP) is down 15% premarket on light volume in response to its announcement of additional data from its CyNCh study assessing lead product candidate RP103 for the treatment of children with moderate-to-severe nonalcoholic fatty liver disease (NAFLD). The results will be presented today at The Liver Meeting in San Francisco.

As previously reported on September 14, there was no statistically valid...